Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Mansoor A Syed"'
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Background Chronic myeloid leukemia (CML) relapse and progression after discontinuation of tyrosine kinase inhibitors (TKI) therapy in the chronic phase (CP) are attributed to primitive quiescent leukemic progenitor cells (LPCs). This study
Externí odkaz:
https://doaj.org/article/9c54cb270298432a9da2f805e50e3c18
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147588 (2016)
The role of vascular endothelial growth factor (VEGF)-induced 3 different nitric oxide synthase (NOS) isoforms in lung development and injury in the newborn (NB) lung are not known. We hypothesized that VEGF-induced specific NOS pathways are critical
Externí odkaz:
https://doaj.org/article/2f9d5af5d76f49db9e72e63992b1599e
Autor:
latif, Misbah, Nawaz, Raziq, Hammad Aziz, Muhammad, Asif, Muhammad, Noor, Fatima, Aligayev, Amil, Mansoor Ali, Syed, Alam, Manawwer, Papanikolaou, Stefanos, Huang, Qing
Publikováno v:
In Separation and Purification Technology 24 December 2024 351
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 27, Iss 3, Pp 326-334 (2024)
Objective(s): Neurological disorders are the world’s most distressing problem. The adverse effects of current medications continue to compel scientists to seek safer, more effective, and economically affordable alternatives. In this vein, we explor
Externí odkaz:
https://doaj.org/article/2cf85134694a48d4bdc6d2731fbceac6
Publikováno v:
In Solid State Communications 1 June 2024 384
Publikováno v:
In Heliyon 15 May 2024 10(9)
Publikováno v:
In Solid State Communications 15 April 2024 382
Autor:
Aldawood, S., Mansoor Ali, Syed
Publikováno v:
In Journal of King Saud University - Science February 2024 36(2)
Autor:
Archana Sharma, Prithvi Singh, Rishabh Jha, Saleh A. Almatroodi, Faris Alrumaihi, Arshad Husain Rahmani, Hajed Obaid Alharbi, Ravins Dohare, Mansoor Ali Syed
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Lung adenocarcinoma (LUAD) is the most common malignant subtype of lung cancer (LC). miR-200 family is one of the prime miR regulators of epithelial-mesenchymal transition (EMT) and worst overall survival (OS) in LC patients. The study aimed
Externí odkaz:
https://doaj.org/article/191fd793feb145658939fe0cdfd1824b
Autor:
Junaid Zaidi, S.M., Sana Ullah Sahar, M., Mansoor Ali, Syed, Ijaz Khan, M., Faizan Shah, Muhammad, Hashim, Muhammad
Publikováno v:
In Results in Optics December 2023 13